Chargement en cours...
Biodistribution and Dosimetry of Intraventricularly Administered (124)I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Radiation dose estimations are key for optimizing therapies. We studied the role of (124)I-omburtamab (8H9) given intraventricularly in assessing the distribution and radiation doses before (131)I-omburtamab therapy in patients with metastatic leptomeningeal disease and compared it with the estimate...
Enregistré dans:
| Publié dans: | J Nucl Med |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Society of Nuclear Medicine
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894373/ https://ncbi.nlm.nih.gov/pubmed/31405921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.219576 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|